ClinicalTrials.gg
RecruitingNCT07330609Updated Jul 28, 2026

Clinical, Radiographic, and Digital Evaluation of the Effects of Autogenous Grafts on Peri-implant Mucosa

An interventional study of Coronal palatal tissue and Apical palatal tissue in Peri-implant Health, Free Gingival Graft and Peri-implant Mucositis, sponsored by Kutahya Health Sciences University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Months and older. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Months and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Mucositis with a site in Turkey — 4 open to participants now, 5 under way, none of them phase 3. Mucositis · Turkey.

Started
2026
with 3 others
No phase
8 of 13
3 open now
Registered
9th of 13
by date
Lead sponsor
1 of 13
Kutahya Health Sciences University

Among the 13 studies in Mucositis with a site in Turkey, this one is one of 4 that started in 2026, is one of 8 with no phase, and was the 9th registered.

Mucositis

265 studies on the registry are indexed under Mucositis; 34 are open to participants now.

Browse Mucositis studies →

Open to participants now

4 of the 13 studies in Mucositis with a site in Turkey are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 21 Mucositis studies recruiting now, 13 (62%) set no upper age limit and 7 (33%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.

This study: 18 Months and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Mucositis with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to evaluate the effects of autogenous grafts harvested from different palatal regions on the peri-implant mucosa when applied during second-stage dental implant surgery.

Clinical, radiographic, and digital assessment methods will be used to investigate the early effects of these grafts on peri-implant mucosal width and thickness. In addition, peri-implant tissue health and patient-reported outcomes will be evaluated to compare the effectiveness of the grafting techniques in peri-implant soft tissue management.

03

Conditions studied

  • Peri-implant Health
  • Free Gingival Graft
  • Peri-implant Mucositis

Browse trials for

04

Who can participate

Ages eligible
18 Months and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over 18 years
  • Systemically healthy patients
  • Presence of premolar or molar tooth loss in the mandible
  • Adequate mesiodistal and interocclusal space for implant and restoration placement
  • At least four months elapsed since tooth extraction
  • Alveolar bone width of at least 6 mm and sufficient alveolar bone height to allow implant placement without compromising anatomical structures
  • Full-mouth plaque and bleeding scores less than 20%
  • Presence of opposing teeth in occlusion
  • Keratinized mucosa width in the relevant region less than 2 mm
  • Keratinized mucosa thickness in the relevant region of 2 mm or less
  • Presence of a healthy second premolar in the maxilla
  • Provision of written and permission for the use of data for research purposes

Exclusion criteria

Exclusion Criteria:

  • Poor oral hygiene
  • Uncontrolled periodontal disease
  • Pregnancy or lactation at any stage of the study
  • Uncontrolled diabetes mellitus
  • patients
  • Previous radiotherapy to the head and neck region
  • Diseases or medications affecting bone metabolism
  • Antibiotic use within the three months prior to the procedure
  • Smoking more than 10 cigarettes per day
  • Pre- or simultaneous bone augmentation prior to implant placement
  • Lack of primary stability at the time of implant placement
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Coronal palatal tissue

    Participants in this group will receive grafts including marginal and interdental palatal gingiva.

    Procedure: Coronal palatal tissue

  • Active comparator
    Apical palatal tissue

    Participants in this group will receive grafts harvested from approximately 1.5 mm apical to the palatal gingival margin.

    Procedure: Apical palatal tissue

Interventions

  • ProcedureCoronal palatal tissue

    This group will receive palatal grafts including marginal and interdental gingiva. This coronal palatal tissue will be applied to the peri-implant tissue at the second-stage implant surgery.

  • ProcedureApical palatal tissue

    This group will receive palatal grafts harvested from approximately 1.5 mm apical to the gingival margin. This graft will be applied to the peri-implant tissue at the second-stage implant surgery.

06

What researchers measure

Primary outcomes

  1. Peri-implant Mucosal Thickness

    The primary outcome is the change in peri-implant mucosal thickness measured at four time points using clinical and digital methods.

    Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)

Secondary outcomes

  1. Keratinized Mucosa Width

    Keratinized tissue width will be measured from the mid-buccal aspect of the edentulous area.

    Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)

  2. Vestibular Depth

    Vestibular depth is defined as the vertical distance between the midcrestal area and the point of greatest concavity of the mucosal fold.

    Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)

  3. Modified Plaque Index

    Modified plaque index will be measured at six points around each implant by an index with a minimum value of 0 and a maximum of 3.

    Time frame: Postoperative 6th month after implant placement and 12th month after prosthetic loading

  4. Modified Bleeding Index

    Modified bleeding index will be measured at six points around each implant by an index with a minimum value of 0 and a maximum of 3.

    Time frame: Postoperative 6th month after implant placement and 12th month after prosthetic loading

  5. Peri- implant Probing Depth

    Peri-implant probing depth will be measured at six points around each implant.

    Time frame: Postoperative 6th month after implant placement and 12th month after prosthetic loading

  6. Mucosal Recession

    Mucosal recession will be measured as the distance between the implant abutment interface and the mucosal margin.

    Time frame: 12th month after prosthetic loading

  7. Marginal Bone Level

    Marginal bone level will be measured on periapical radiographs taken by the parallel technique.

    Time frame: Pre-operative and post-operative (before implant placement, 3rd month (second-stage implant surgery), 6th month after implant placement, and 12th month after prosthetic loading)

  8. Pink Esthetic Score (PES)

    Peri-implant soft tissue esthetics will be evaluated using the Pink Esthetic Score with a minimum value of 0 and a maximum of 14.

    Time frame: Postoperative 3rd month (second-stage implant surgery) and 12th month after prosthetic loading

  9. Postoperative Pain Assessment

    Postoperative pain as patient-reported outcome will be recorded using a visual analog scale (VAS; 0-100).

    Time frame: Postoperative 14 days (daily after graft application)

  10. Analgesic Consumption

    The amount of analgesic medication used (mg) will be recorded.

    Time frame: Postoperative 14.days (after graft application)

  11. Patient Satisfaction

    Patient satisfaction with the surgical procedure will be assessed using a three-point Likert scale (0 = no, 1 = maybe, 2 = yes).

    Time frame: Postoperative 14.days (after graft application)

  12. Patient-Perceived Esthetic Outcome

    Patient perception of peri-implant soft tissue esthetics will be evaluated using a visual analog scale (VAS; 0-100).

    Time frame: 12th month after prosthetic loading

  13. Oral Health-Related Quality of Life

    Oral health-related quality of life will be assessed using the Oral Health Impact Profile (OHIP-14) questionnaire.

    Time frame: Postoperative 3rd month (second-stage implant surgery) and 12th month after prosthetic loading

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Zigdon H, Machtei EE. The dimensions of keratinized mucosa around implants affect clinical and immunological parameters. Clin Oral Implants Res. 2008 Apr;19(4):387-92. doi: 10.1111/j.1600-0501.2007.01492.x. Epub 2008 Feb 11. PubMed 18266873 ↗
  • Bassetti RG, Stahli A, Bassetti MA, Sculean A. Soft tissue augmentation procedures at second-stage surgery: a systematic review. Clin Oral Investig. 2016 Sep;20(7):1369-87. doi: 10.1007/s00784-016-1815-2. Epub 2016 Apr 4. PubMed 27041111 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Aug 2027, 18 months after the start.

Of 67 non-industry interventional studies with no phase under Mucositis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 26. This study's planned 18 months is above that.

Counting every sponsor, half of 70 studies reached it within 12 months; a quarter within 6 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2025
First posted
Jan 9, 2026
StartActual
Feb 2, 2026
Primary completionEst.
Aug 2, 2027
CompletionEst.
Nov 1, 2027
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07330609
Responsible party
Ezgi Gürbüz (Associate Professor, Kutahya Health Sciences University) — Principal investigator
First posted
Jan 9, 2026
Start date
Feb 2, 2026
Primary completion
Aug 2, 2027 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Jul 28, 2026

Study contacts

Ezgi Gürbüz
Contact
ezgi.dogan@ksbu.edu.tr
+905557411860

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion